Clinical Trial Supply and Logistics Market for Pharma 2025-2035
Description
The Clinical Trial Supply and Logistics Market for Pharma 2025-203 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Global supply chains remain highly vulnerable to shocks, whether from pandemics, geopolitical conflicts, or raw material shortages. Rising air freight costs, port congestion, and customs delays disrupt timelines and jeopardise trial integrity. These challenges are pushing sponsors to partner with logistics providers that can offer diversified transport options, strategically located regional depots, and robust contingency planning. Providers unable to guarantee business continuity risk both reputational damage and commercial losses. As a result, resilience and redundancy have become critical differentiators in partner selection, reshaping the competitive dynamics of the clinical trial supply and logistics (CTSL) market.
The imposition of U.S. trade tariffs is expected to create ripple effects across the global clinical trial supply and logistics (CTSL) market, particularly as companies dependent on cross-border movement of trial materials face mounting operational costs. Increased tariffs on imported APIs, packaging materials, and specialised equipment can slow procurement processes and tighten budgets, especially for trials that rely on just-in-time delivery models. This environment of heightened uncertainty risks delaying clinical milestones and extending development timelines for new therapies.
Beyond the immediate financial impact, tariffs are likely to influence long-term strategic decisions. Pharmaceutical sponsors and logistics providers may increasingly localise supply chains, invest in regional distribution hubs, or establish tariff-free trade routes to safeguard competitiveness. However, smaller firms with limited resources could struggle to absorb additional costs, widening the gap between global players and niche service providers. In this way, U.S. tariffs not only add pressure to the cost base of trial logistics but also redefine the competitive landscape of the industry.
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035, with a focus on this segment of these companies' operations.
Overall world revenue for Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 in terms of value the market will surpass US$16.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
In summary, our 270+ page report provides you with the following knowledge:
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
Supply Chain Disruptions Pose Market Challenges
Global supply chains remain highly vulnerable to shocks, whether from pandemics, geopolitical conflicts, or raw material shortages. Rising air freight costs, port congestion, and customs delays disrupt timelines and jeopardise trial integrity. These challenges are pushing sponsors to partner with logistics providers that can offer diversified transport options, strategically located regional depots, and robust contingency planning. Providers unable to guarantee business continuity risk both reputational damage and commercial losses. As a result, resilience and redundancy have become critical differentiators in partner selection, reshaping the competitive dynamics of the clinical trial supply and logistics (CTSL) market.
What would be the Impact of US Trade Tariffs on the Global Clinical Trial Supply and Logistics for Pharma Market?
The imposition of U.S. trade tariffs is expected to create ripple effects across the global clinical trial supply and logistics (CTSL) market, particularly as companies dependent on cross-border movement of trial materials face mounting operational costs. Increased tariffs on imported APIs, packaging materials, and specialised equipment can slow procurement processes and tighten budgets, especially for trials that rely on just-in-time delivery models. This environment of heightened uncertainty risks delaying clinical milestones and extending development timelines for new therapies.
Beyond the immediate financial impact, tariffs are likely to influence long-term strategic decisions. Pharmaceutical sponsors and logistics providers may increasingly localise supply chains, invest in regional distribution hubs, or establish tariff-free trade routes to safeguard competitiveness. However, smaller firms with limited resources could struggle to absorb additional costs, widening the gap between global players and niche service providers. In this way, U.S. tariffs not only add pressure to the cost base of trial logistics but also redefine the competitive landscape of the industry.
What Questions Should You Ask before Buying a Market Research Report?
- How is the clinical trial supply and logistics for pharma market evolving?
- What is driving and restraining the clinical trial supply and logistics for pharma market?
- How will each clinical trial supply and logistics for pharma submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
- How will the market shares for each clinical trial supply and logistics for pharma submarket develop from 2025 to 2035?
- What will be the main driver for the overall market from 2025 to 2035?
- Will leading clinical trial supply and logistics for pharma markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
- Who are the leading players and what are their prospects over the forecast period?
- What are the clinical trial supply and logistics for pharma projects for these leading companies?
- How will the industry evolve during the period between 2025 and 2035? What are the implications of
clinical trial supply and logistics for pharma projects taking place now and over the next 10 years? - Is there a greater need for product commercialisation to further scale the clinical trial supply and logistics for pharma market?
- Where is the clinical trial supply and logistics for pharma market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial supply and logistics for pharma market today, and over the next 10 years:
- Our 272-page report provides 115 tables and 129 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2035 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2035, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Type
- CTS Manufacturing
- CTS Logistics & Distribution
- CT Supply Chain Management
- CTS Packaging & Storage
Phase
- Preclinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Post Launch
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 26 leading national markets:
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Switzerland
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- South-East Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
MEA
- GCC
- South Africa
- Rest of MEA
The report also includes profiles and for some of the leading companies in the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035, with a focus on this segment of these companies' operations.
Leading companies and the potential for market growth
- Almac Group
- Bilcare Limited
- Biocair
- Catalent, Inc.
- COREX Logistics
- Eurofins Scientific
- FedEx
- ICON plc
- Intertek Group plc
- Kerry Logistics Network Limited
- Kuehne+Nagel
- Marken (A UPS Company)
- Mayne Pharma Group Limited
- Movianto
- NAF Pharma
- Oximio
- Parexel International Corporation
- PCI Pharma Services (PCI)
- Royal Cargo
- Thermo Fisher Scientific Inc.
- United Parcel Service, Inc.
- Yourway
Overall world revenue for Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 in terms of value the market will surpass US$16.0 billion in 2025, our work calculates. We predict strong revenue growth through to 2035.
Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Clinical Trial Supply and Logistics Market for Pharma, 2025 to 2035 report help you?
In summary, our 270+ page report provides you with the following knowledge:
- Revenue forecasts to 2035 for Clinical Trial Supply and Logistics Market for Pharma 2025 to 2035, with forecasts for type and phase, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2035 for five regional and 26 key national markets - See forecasts for the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 25 of the major companies involved in the Clinical Trial Supply and Logistics for Pharma Market, 2025 to 2035.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Clinical Trial Supply and Logistics for Pharma Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.
Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
Table of Contents
272 Pages
- 1 Report Overview
- 1.1 Objectives of the Study
- 1.2 Introduction to Clinical Trial Supply and Logistics for Pharma Market
- 1.3 What This Report Delivers
- 1.4 Why You Should Read This Report
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Market Definitions
- 1.7.2 Market Evaluation & Forecasting Methodology
- 1.7.3 Data Validation
- 1.7.3.1 Primary Research
- 1.7.3.2 Secondary Research
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
- 2 Executive Summary
- 3 Market Overview
- 3.1 Key Findings
- 3.2 Market Dynamics
- 3.2.1 Market Driving Factors
- 3.2.1.1 Move Towards Decentralized/Virtual Trials
- 3.2.1.2 Increasing Possibilities for Conducting Clinical Trials in Asia Pacific Nations
- 3.2.1.3 Growing Clinical Trials Volume
- 3.2.1.4 Integrated Solution to Track Clinical Trials
- 3.2.2 Market Restraining Factors
- 3.2.2.1 Clinical Trial and Medical Cold Chain Logistics
- 3.2.2.2 Man-made or Natural Disruption in Transportation
- 3.2.2.3 High Financial Cost
- 3.2.3 Market Opportunities
- 3.2.3.1 AI and Machine Learning are Evolving with More Data
- 3.2.3.2 Virtual Trials and Technology Are Gaining Acceptance among Patients and Sites
- 3.2.3.3 Big Companies are driving the Market
- 3.1 U.S. Tariffs: What's the Impact on Global Clinical Trial Supply and Logistics for Pharma Market?
- 3.1.1 Overview
- 3.1.2 V-Shaped Recovery Scenario
- 3.1.3 Why V-Shaped Recovery?
- 3.1.3.1 Impact from Tariffs
- 3.1.3.2 Market Dynamics and Demand Recovery
- 3.1.3.3 Policy and Funding Support
- 3.1.3.4 Timeframe for Recovery
- 3.1.4 U-Shaped Recovery Scenario
- 3.1.4.1 Why U-Shaped Recovery?
- 3.1.4.2 Impact from Tariffs
- 3.1.4.3 Market Dynamics and Demand Recovery
- 3.1.4.4 Policy and Funding Support
- 3.1.4.5 Timeframe for Recovery
- 3.1.5 L Shaped Recovery Scenario
- 3.1.5.1 Why L-Shaped Recovery?
- 3.1.5.2 Impact from Tariffs
- 3.1.5.3 Market Dynamics and Demand Recovery
- 3.1.5.4 Policy and Funding Support
- 3.1.5.5 Timeframe for Recovery
- 3.1.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
- 3.1.7 Impact of U.S. and China Trade War on Clinical Trial Supply and Logistics for Pharma Market
- 3.1.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
- 3.2 Porter's Five Forces Analysis
- 3.2.1 Bargaining Power of Suppliers
- 3.2.2 Bargaining Power of Buyers
- 3.2.3 Competitive Rivalry
- 3.2.4 Threat of Substitutes
- 3.2.5 Threat of New Entrants
- 3.3 PEST Analysis
- 4 Clinical Trial Supply and Logistics for Pharma Market Analysis by Type
- 4.1 Key Findings
- 4.2 Type Segment: Market Attractiveness Index
- 4.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 4.4 CTS Manufacturing
- 4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 4.4.2 Market Share by Region, 2025 & 2035 (%)
- 4.5 CTS Logistics & Distribution
- 4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 4.5.2 Market Share by Region, 2025 & 2035 (%)
- 4.6 CT Supply Chain Management
- 4.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 4.6.2 Market Share by Region, 2025 & 2035 (%)
- 4.7 CTS Packaging & Storage
- 4.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 4.7.2 Market Share by Region, 2025 & 2035 (%)
- 5 Clinical Trial Supply and Logistics for Pharma Market Analysis by Phase
- 5.1 Key Findings
- 5.2 Phase Segment: Market Attractiveness Index
- 5.3 Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 5.4 Preclinical
- 5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.4.2 Market Share by Region, 2025 & 2035 (%)
- 5.5 Phase I
- 5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.5.2 Market Share by Region, 2025 & 2035 (%)
- 5.6 Phase II
- 5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.6.2 Market Share by Region, 2025 & 2035 (%)
- 5.7 Phase III
- 5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.7.2 Market Share by Region, 2025 & 2035 (%)
- 5.8 Phase IV
- 5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.8.2 Market Share by Region, 2025 & 2035 (%)
- 5.9 Post Launch
- 5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
- 5.9.2 Market Share by Region, 2025 & 2035 (%)
- 6 Clinical Trial Supply and Logistics for Pharma Market Analysis by Region
- 6.1 Key Findings
- 6.2 Regional Market Size Estimation and Forecast
- 7 North America Clinical Trial Supply and Logistics for Pharma Market Analysis
- 7.1 Key Findings
- 7.2 North America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 7.3 North America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 7.4 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 7.5 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 7.6 North America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 7.7 U.S. Clinical Trial Supply and Logistics for Pharma Market Analysis
- 7.8 Canada Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8 Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.1 Key Findings
- 8.2 Europe Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 8.3 Europe Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 8.4 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 8.5 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 8.6 Europe Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 8.7 Germany Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.8 UK Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.9 France Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.10 Italy Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.11 Spain Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.12 Russia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.13 Netherlands Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.14 Switzerland Clinical Trial Supply and Logistics for Pharma Market Analysis
- 8.15 Rest of Europe Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.1 Key Findings
- 9.2 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 9.3 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 9.4 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 9.5 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 9.6 Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 9.7 Japan Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.8 China Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.9 India Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.10 Australia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.11 South Korea Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.12 South-East Asia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 9.13 Rest of Asia Pacific Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10 Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.1 Key Findings
- 10.2 Latin America Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 10.3 Latin America Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 10.4 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 10.5 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 10.6 Latin America Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 10.7 Brazil Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.8 Mexico Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.9 Argentina Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.10 Colombia Clinical Trial Supply and Logistics for Pharma Market Analysis
- 10.11 Rest of Latin America Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11 MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.1 Key Findings
- 11.2 MEA Clinical Trial Supply and Logistics for Pharma Market Attractiveness Index
- 11.3 MEA Clinical Trial Supply and Logistics for Pharma Market by Country, 2025, 2030 & 2035 (US$ Billion)
- 11.4 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Country
- 11.5 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Type
- 11.6 MEA Clinical Trial Supply and Logistics for Pharma Market Size Estimation and Forecast by Phase
- 11.7 GCC Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.8 South Africa Clinical Trial Supply and Logistics for Pharma Market Analysis
- 11.9 Rest of MEA Clinical Trial Supply and Logistics for Pharma Market Analysis
- 12 Company Profiles
- 12.1 Catalent, Inc.
- 12.1.1 Company Snapshot
- 12.1.2 Company Overview
- 12.1.3 Financial Analysis
- 12.1.3.1 Net Revenue, 2020-2024
- 12.1.3.2 Regional Market Shares, 2024
- 12.1.4 Service Benchmarking
- 12.1.5 Strategic Outlook
- 12.2 Thermo Fisher Scientific Inc.
- 12.2.1 Company Snapshot
- 12.2.2 Company Overview
- 12.2.3 Financial Analysis
- 12.2.3.1 Net Revenue, 2020-2024
- 12.2.3.2 R&D, 2020-2024
- 12.2.3.3 Regional Market Shares, 2024
- 12.2.4 Service Benchmarking
- 12.2.5 Strategic Outlook
- 12.3 ICON plc
- 12.3.1 Company Snapshot
- 12.3.2 Company Overview
- 12.3.3 Financial Analysis
- 12.3.3.1 Revenue, 2020-2024
- 12.3.3.2 Regional Market Shares, 2023
- 12.3.4 Service Benchmarking
- 12.3.5 Strategic Outlook
- 12.4 Eurofins Scientific
- 12.4.1 Company Snapshot
- 12.4.2 Company Overview
- 12.4.3 Financial Analysis
- 12.4.3.1 Net Revenue, 2019-2022
- 12.4.4 Services Offered
- 12.4.5 Strategic Outlook
- 12.5 FedEx
- 12.5.1 Company Snapshot
- 12.5.2 Company Overview
- 12.5.3 Financial Analysis
- 12.5.3.1 Net Revenue, 2020-2024
- 12.5.3.2 Regional Market Shares, 2024
- 12.5.4 Service Benchmarking
- 12.6 United Parcel Service, Inc.
- 12.6.1 Company Snapshot
- 12.6.2 Company Overview
- 12.6.3 Financial Analysis
- 12.6.3.1 Net Revenue, 2020-2024
- 12.6.4 Service Benchmarking
- 12.7 Cencora, Inc.
- 12.7.1 Company Snapshot
- 12.7.2 Company Overview
- 12.7.3 Financial Analysis
- 12.7.3.1 Net Revenue, 2020-2024
- 12.7.4 Service Benchmarking
- 12.8 DHL Group
- 12.8.1 Company Snapshot
- 12.8.2 Company Overview
- 12.8.3 Financial Analysis
- 12.8.3.1 Net Revenue, 2020-2024
- 12.8.4 Service Benchmarking
- 12.9 DKSH Holding Ltd.
- 12.9.1 Company Snapshot
- 12.9.2 Company Overview
- 12.9.3 Service Benchmarking
- 12.10 KERRY LOGISTICS NETWORK LIMITED
- 12.10.1 Company Snapshot
- 12.10.2 Company Overview
- 12.10.3 Financial Analysis
- 12.10.3.1 Net Revenue, 2019-2023
- 12.10.3.2 Regional Market Shares, 2024
- 12.10.4 Service Benchmarking
- 12.11 Kuehne+Nagel
- 12.11.1 Company Snapshot
- 12.11.2 Company Overview
- 12.11.3 Financial Analysis
- 12.11.3.1 Net Revenue, 2020-2024
- 12.11.3.2 Regional Market Shares, 2024
- 12.11.4 Service Benchmarking
- 12.11.5 Strategic Outlook
- 12.12 Bilcare Limited
- 12.12.1 Company Snapshot
- 12.12.2 Company Overview
- 12.12.3 Service Benchmarking
- 12.13 Mayne Pharma Group Limited
- 12.13.1 Company Snapshot
- 12.13.2 Company Overview
- 12.13.3 Financial Analysis
- 12.13.3.1 Net Revenue, 2020-2024
- 12.13.3.2 Regional Market Shares, 2024
- 12.13.4 Service Benchmarking
- 12.14 Intertek Group plc
- 12.14.1 Company Snapshot
- 12.14.2 Company Overview
- 12.14.3 Financial Analysis
- 12.14.3.1 Net Revenue, 2020-2024
- 12.14.4 Service Benchmarking
- 12.15 Almac Group
- 12.15.1 Company Snapshot
- 12.15.2 Company Overview
- 12.15.3 Service Benchmarking
- 12.15.4 Strategic Outlook
- 12.16 Parexel International Corporation
- 12.16.1 Company Snapshot
- 12.16.2 Company Overview
- 12.16.3 Service Benchmarking
- 12.16.4 Strategic Outlook
- 12.17 Biocair
- 12.17.1 Company Snapshot
- 12.17.2 Company Overview
- 12.17.3 Service Benchmarking
- 12.17.4 Strategic Outlook
- 12.18 Marken (A UPS Company)
- 12.18.1 Company Snapshot
- 12.18.2 Company Overview
- 12.18.3 Service Benchmarking
- 12.19 PCI Pharma Services (PCI)
- 12.19.1 Company Snapshot
- 12.19.2 Company Overview
- 12.19.3 Service Benchmarking
- 12.19.4 Strategic Outlook
- 12.20 Movianto
- 12.20.1 Company Snapshot
- 12.20.2 Company Overview
- 12.20.3 Service Benchmarking
- 12.21 Yourway
- 12.21.1 Company Snapshot
- 12.21.2 Company Overview
- 12.21.3 Service Benchmarking
- 12.22 COREX Logistics
- 12.22.1 Company Snapshot
- 12.22.2 Company Overview
- 12.22.3 Service Benchmarking
- 12.23 Oximio
- 12.23.1 Company Snapshot
- 12.23.2 Company Overview
- 12.23.3 Service Benchmarking
- 12.24 Royal Cargo
- 12.24.1 Company Snapshot
- 12.24.2 Company Overview
- 12.24.3 Service Benchmarking
- 12.25 NAF Pharma
- 12.25.1 Company Snapshot
- 12.25.2 Company Overview
- 12.25.3 Service Benchmarking
- 13 Conclusion and Recommendations
- 13.1 Concluding Remarks from Visiongain
- 13.2 Recommendations for Market Players
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.